About

Fiona McLaughlin, PhD, Head of Research and Development at N4 Pharma, is an experienced oncology drug developer and independent consultant, bringing over 25 years of experience in research and translational drug development in the pharmaceutical and biotech sectors, having led teams from early research through to clinical development. Dr McLaughlin started her career at GSK and has held leadership positions in biotech companies including Avacta Therapeutics, Algeta ASA (now Bayer), Antisoma plc and BTG plc (now part of Boston Scientific). She is also a non-executive director of Hox Therapeutics. Dr McLaughlin received a PhD from the Haematology Department at Cambridge University (UK) and has a BSc in Biochemistry from Glasgow University (UK).